Centre for Epidemiology Versus Arthritis

Recent papers from Centre for Epidemiology Versus Arthritis

1. Identifying biomarkers for methotrexate efficacy in rheumatoid arthritis: a machine learning approach to whole-blood transcriptomic analysisLara D. Veeken · 2026
2. Perceptions, knowledge and adoption of artificial intelligence in rheumatology: results from a British Society for Rheumatology surveyLara D. Veeken · 2026
3. The WORKWELL programme: a randomised controlled trial of job retention vocational rehabilitation for people with inflammatory arthritisLara D. Veeken · 2026
4. Extending BEHRT to UK Biobank: assessing transformer model performance in clinical predictionSHILAP Revista de lepidopterología · 2026
5. Disease activity and mental health symptoms in axial spondyloarthritis: concordant or discordant?Lara D. Veeken · 2025
6. The Michael Mason Prize: Development and feasibility testing of a complex intervention to improve adherence to fracture prevention medicineLara D. Veeken · 2025
7. Pre-treatment GlycA measurement provides no additional predictive utility beyond routine clinical measures in patients with rheumatoid arthritisLara D. Veeken · 2025
8. WORKWELL process evaluation: qualitative data analyses of the participant interviews at 12- and 36-month follow-upsRheumatology Advances in Practice · 2025
9. Comparative risk of mortality in new users of prescription opioids for noncancer pain: results from the International Pharmacosurveillance StudyPain · 2024
10. Op0022 Genetic Risk Markers Are Associated With Clinical Measures in a Cohort of Jia PatientsAnnals of the Rheumatic Diseases · 2024
11. Op0111 Quiescent Human Blood Monocyte States Are Pre-Committed to an Inflammatory Synovial Transcriptional ProgramAnnals of the Rheumatic Diseases · 2024
12. Ab0757 Treatment Response Criteria for the Two-Component Disease Activity ScoreAnnals of the Rheumatic Diseases · 2024
13. E055 The experience of pain in patients with rheumatoid arthritis - findings from a qualitative study of REMORA app users’ experiencesLara D. Veeken · 2024
14. Novel genetic loci, lifestyle factors, and inflammatory markers identified as risk factors for sarcoidosis2024
15. Use of over-the-counter supplements, sleep aids and analgesic medicines in rheumatology: results of a cross-sectional surveyRheumatology Advances in Practice · 2024
16. Evaluation of discontinuation for adverse events of JAK inhibitors and bDMARDs in an international collaboration of rheumatoid arthritis registers (the ‘JAK-pot’ study)Annals of the Rheumatic Diseases · 2023
17. Causal association between subtypes of osteoarthritis and common comorbidities: A Mendelian randomisation studyOsteoarthritis and Cartilage Open · 2023
18. Proteomic analysis identifies subgroups of patients with active systemic lupus erythematosusClinical Proteomics · 2023
19. Association Between Severe Nonadherence to Hydroxychloroquine and Systemic Lupus Erythematosus Flares, Damage, and Mortality in 660 Patients From the SLICC Inception CohortArthritis & Rheumatology · 2023
20. The Effect of COVID-19 on Medication Adherence in a Rheumatoid Arthritis (BRAGGSS) and Psoriatic Arthritis (OUTPASS) UK CohortThe Journal of Rheumatology · 2023